SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001739104-24-000016
Filing Date
2024-05-08
Accepted
2024-05-08 06:28:29
Documents
15
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K DATED MAY 8, 2024 elan-20240508.htm   iXBRL 8-K 27332
2 EXHIBIT 99.1 PRESS RELEASE DATED MAY 8, 2024 elanco-20240331exhibit991.htm EX-99.1 276188
6 GRAPHIC image1.jpg GRAPHIC 214321
  Complete submission text file 0001739104-24-000016.txt   717445

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20240508.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20240508_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20240508_pre.xml EX-101.PRE 12518
18 EXTRACTED XBRL INSTANCE DOCUMENT elan-20240508_htm.xml XML 2703
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 24924123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)